Insulet Corp. Stock
Price
Target price
€246.60
€246.60
0.650%
1.6
0.650%
€316.53
17.12.25 / Tradegate
WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insulet Corp. Stock
The Insulet Corp. stock is trending slightly upwards today, with an increase of €1.60 (0.650%) compared to yesterday's price.
With 45 Buy predictions and not a single Sell prediction Insulet Corp. is an absolute favorite of our community.
As a result the target price of 316 € shows a positive potential of 28.14% compared to the current price of 246.6 € for Insulet Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Insulet Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Insulet Corp. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | 0.650% | -2.337% | -12.862% | -1.792% | -2.026% | -12.646% | 25.528% |
| Icu Medical Inc. | 0.000% | 1.639% | 5.983% | -16.779% | -15.646% | -15.646% | -25.749% |
| Bio-Rad Labs Inc. A | -0.310% | -4.716% | -2.173% | -20.286% | -18.306% | -33.420% | -46.318% |
| Neogen Corp. | 1.670% | 0.833% | 9.009% | -46.460% | -49.583% | - | - |
Comments
Insulet (NASDAQ:PODD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $370.00 price target on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (NASDAQ:PODD) was given a new $412.00 price target on by analysts at Truist Financial Corporation. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
News
Insulet (PODD) Q2 Revenue Jumps 33%
Insulet (NASDAQ:PODD), a medical device company specializing in wearable insulin delivery systems, released its second quarter 2025 earnings on August 7, 2025. The headline news was strong
